Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
Johnson and Johnson
Baxter
McKinsey
Mallinckrodt

Last Updated: January 18, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR SUMATRIPTAN

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

All Clinical Trials for Sumatriptan

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00122278 Headache in the Emergency Department (ED) - A Multi-Center Research Network to Optimize the ED Treatment of Migraines Completed Montefiore Medical Center Phase 3 2005-07-01 Migraines are a specific type of headache that frequently recur and are very painful. Although there are many medications that are effective against migraines, none of these medications cure 100% of migraines. Another problem with migraines is that although many times they get better after intravenous (IV) treatment in the emergency room (ER), about 1/3 of the time migraines recur the next day. The purpose of this research project is to see if adding a medication called dexamethasone to standard ER therapy will help patients get better quicker and stay pain-free more often than if they receive placebo.
NCT00184587 Prophylactic Treatment of Episodic Cluster Headache Completed AstraZeneca Phase 2 2005-03-01 The purpose of this study is to determine whether candesartan cilexetil are effective prophylactic treatment of episodic Cluster headache
NCT00184587 Prophylactic Treatment of Episodic Cluster Headache Completed Norwegian University of Science and Technology Phase 2 2005-03-01 The purpose of this study is to determine whether candesartan cilexetil are effective prophylactic treatment of episodic Cluster headache
NCT00240617 Study Of Treximet, Formerly Known as Trexima, In The Acute Treatment Of Multiple Migraine Attacks Completed GlaxoSmithKline Phase 3 2005-10-01 The purpose of this study is to determine the consistency of response for Treximet (formerly known as Trexima) when treating four acute migraine attacks at the mild pain phase and within 1 hour of onset of head pain.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Sumatriptan

Condition Name

Condition Name for Sumatriptan
Intervention Trials
Migraine Disorders 29
Migraine 24
Healthy 11
Migraine Without Aura 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Sumatriptan
Intervention Trials
Migraine Disorders 74
Headache 30
Migraine without Aura 7
Cluster Headache 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Sumatriptan

Trials by Country

Trials by Country for Sumatriptan
Location Trials
United States 468
Denmark 14
China 4
India 3
Canada 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Sumatriptan
Location Trials
Florida 26
California 25
New York 24
Missouri 23
Michigan 22
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Sumatriptan

Clinical Trial Phase

Clinical Trial Phase for Sumatriptan
Clinical Trial Phase Trials
Phase 4 12
Phase 3 32
Phase 2/Phase 3 3
[disabled in preview] 11
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Sumatriptan
Clinical Trial Phase Trials
Completed 77
Recruiting 14
Not yet recruiting 5
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Sumatriptan

Sponsor Name

Sponsor Name for Sumatriptan
Sponsor Trials
GlaxoSmithKline 25
Danish Headache Center 11
NuPathe Inc. 8
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Sumatriptan
Sponsor Trials
Industry 77
Other 45
U.S. Fed 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
Medtronic
McKesson
Colorcon
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.